Atomistry » Zinc » PDB 2w22-2wfr » 2weo
Atomistry »
  Zinc »
    PDB 2w22-2wfr »
      2weo »

Zinc in PDB 2weo: Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

Enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors

All present enzymatic activity of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors:
4.2.1.1;

Protein crystallography data

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weo was solved by A.D.Scott, C.Phillips, A.Alex, A.Bent, R.O'brien, L.Damian, L.H.Jones, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 19.96 / 1.40
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 42.511, 41.291, 74.008, 90.00, 109.50, 90.00
R / Rfree (%) 16.7 / 18.5

Other elements in 2weo:

The structure of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors also contains other interesting chemical elements:

Fluorine (F) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors (pdb code 2weo). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors, PDB code: 2weo:

Zinc binding site 1 out of 1 in 2weo

Go back to Zinc Binding Sites List in 2weo
Zinc binding site 1 out of 1 in the Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Thermodynamic Optimisation of Carbonic Anhydrase Fragment Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn1262

b:6.0
occ:1.00
 N2 A:FBW1263 2.0 6.5 1.0
NE2 A:HIS94 2.0 6.0 1.0
ND1 A:HIS119 2.1 6.7 1.0
NE2 A:HIS96 2.1 5.8 1.0
CE1 A:HIS119 2.9 6.6 1.0
CD2 A:HIS94 3.0 6.6 1.0
O2 A:FBW1263 3.0 6.2 1.0
S A:FBW1263 3.0 6.7 1.0
CD2 A:HIS96 3.0 5.4 1.0
CE1 A:HIS94 3.1 6.7 1.0
CE1 A:HIS96 3.1 5.9 1.0
CG A:HIS119 3.2 5.9 1.0
CB A:HIS119 3.6 5.8 1.0
OG1 A:THR199 3.9 6.4 1.0
OE1 A:GLU106 4.0 7.3 1.0
C4 A:FBW1263 4.1 7.0 1.0
O1 A:FBW1263 4.1 7.2 1.0
NE2 A:HIS119 4.1 6.0 1.0
CG A:HIS94 4.1 5.7 1.0
ND1 A:HIS94 4.1 6.0 1.0
ND1 A:HIS96 4.2 6.2 1.0
CG A:HIS96 4.2 6.0 1.0
CD2 A:HIS119 4.2 5.8 1.0
C3 A:GOL1264 4.4 9.6 1.0
C5 A:FBW1263 4.8 8.6 1.0
C3 A:FBW1263 4.9 9.1 1.0
CD A:GLU106 5.0 8.4 1.0

Reference:

A.D.Scott, C.Phillips, A.Alex, M.Flocco, A.Bent, A.Randall, R.O'brien, L.Damian, L.H.Jones. Thermodynamic Optimisation in Drug Discovery: A Case Study Using Carbonic Anhydrase Inhibitors. Chemmedchem V. 4 1985 2009.
ISSN: ISSN 1860-7179
PubMed: 19882701
DOI: 10.1002/CMDC.200900386
Page generated: Thu Oct 17 04:53:11 2024

Last articles

Mn in 9GMX
Mn in 9G1S
Mn in 9G1R
Mn in 9G1Q
Mn in 9G1P
Mn in 9G1L
Mn in 9G1M
Mn in 9G1N
Mn in 9G1O
Mn in 9G1H
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy